Comparing quality of life in prostate cancer patients: Continuous vs. intermittent androgen deprivation therapy—A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ...
Functional cure required HBV DNA <LLOQ and undetectable HBsAg for ≥24 weeks off all therapy, achieved in 127/650 and 106/570 bepirovirsen-treated patients (P<.001). Lower baseline HBsAg (≤1000 IU/mL) ...
Creative Biogene is a dedicated research solutions provider focused on developing cutting-edge platforms for cancer therapy and preclinical studies. The team of seasoned scientists, bioinformatics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results